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Sleep problems in bipolar disorders: more
than just insomnia
Steinan MK, Scott J, Lagerberg TV, Melle I, Andreassen OA, Vaaler
AE, Morken G. Sleep problems in bipolar disorders: more than just
insomnia.
Objective: Sleep problems in bipolar disorder (BD) are common, but
reported rates vary from 10% to 80%, depending on definitions,
methodologies and management of potential confounding factors. This
multicenter study seeks to address these issues and also compares BD
cases with Hypersomnia as well as the more commonly investigated
Insomnia and No Sleep Problem groups.
Method: A cross-sectional comparison of sleep profiles in 563 BD I and
II individuals who participated in a structured assessment of
demographic, clinical, illness history and treatment variables.
Results: Over 40% cases met criteria for Insomnia and 29% for
Hypersomnia. In univariate analysis, Insomnia was associated with BD
II depression whilst Hypersomnia was associated with BD I depression
or euthymia. After controlling for confounders and covariates, it was
demonstrated that Hypersomnia cases were significantly more likely to
be younger, have BD I and be prescribed antidepressants whilst
Insomnia cases had longer illness durations and were more likely to be
prescribed benzodiazepines and hypnotics.
Conclusion: Whilst Insomnia symptoms are common in BD,
Hypersomnia is a significant, frequently underexplored problem.
Detailed analyses of large representative clinical samples are critical to
extending our knowledge of differences between subgroups defined by
sleep profile.
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Significant outcomes
• In a cross-sectional clinical study of bipolar disorder (BD) patients in Norway, we found high rates
of Insomnia (40%), but also of Hypersomnia (29%).
• Hypersomnia is a significant and underexplored problem in BD. In this study, Hypersomnia cases
were significantly more likely to be younger, BD I and prescribed antidepressants.
• This is one of the first studies of sleep in BD that adequately controls for confounding factors such as
age, body mass index and prescribed medications.
Limitations
• The cross-sectional design means we can only examine statistical associations, not predictors of sleep
profile or long-term consequences of the different patterns.
• We used no objective sleep measurements in the study.
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Introduction
Bipolar disorder (BD) is a serious, chronic and
recurring condition in which sleep disturbance is a
common symptom regardless of phase of illness
(1–3). Sleep disturbance is the most recognized
prodromal symptom of mania (4) and is one of its
diagnostic criteria, and improvement in sleep is an
important therapeutic target in mania as it often
heralds the restabilization of the current mental
state (5). Likewise, sleep problems are reported in
50–90% of patients with syndromal or subsyndro-
mal depressive symptoms in BD (6). Sleep distur-
bance is frequently the last symptom to resolve as
an affective episode finishes (7), although for many
individuals, it does not fully remit and remains a
persistent interepisode symptom (8, 9). In sum,
changes in sleep pattern predict new episodes and
are a prognostic marker for episode outcomes, for
all polarities of BD (5, 8).
Given the ubiquitous nature of sleep disruptions
in BD, it is unsurprising that they have begun to
receive greater attention. Several clinical studies
have explored the sleep profiles of BD cases and
identified a range of individual characteristics asso-
ciated with the presence or absence of sleep prob-
lems. Also, a number of research studies have
employed actigraphy or other objective measures to
record sleep patterns and their associations with
circadian or other systemic disturbances (8, 10–12).
In addition, exploring how sleep symptoms respond
to the treatments prescribed for acute BD episodes,
there is increasing interest in the adjunctive use of
chronobiotics such as melatonin agonists and/or
chronotherapeutics such as cognitive and beha-
vioural therapies to specifically target sleep prob-
lems in BD cases (8, 10–12). However, these
approaches have exposed the lack of a full under-
standing of the range of sleep profiles that may be
observed in BD and as yet it is not known whether
the reported sleep patterns are mainly associated
with different phases or subtypes of BD and/or how
much of the variance in sleep might be explained by
other known influences such as age, gender, body
mass index (BMI) or indeed be a result of the con-
founding effects of BD treatments (13).
Previous studies have reported differences in
sleep problems between euthymic, depressed,
hypomanic, manic or mixed states [e.g. Gruber
et al. (14)], and between BD subtypes such as BD I
and BD II e.g. Brill et al. (15). However, attempts
to define any other characteristics of BD cases with
or without sleep problems have been undermined
by the fact that studies rarely differentiate between
cases with insomnia, hypersomnia and/or any
other sleep disturbance, an exception is Soehner
et al. (16). Furthermore, apart from the large-scale
study of sleep profiles from the STEP-BD pro-
gramme, the vast majority of clinical studies of
sleep in BD include only a small numbers of partic-
ipants (average around 50) who are often recruited
from specialist clinics. Thus, there is a lack of
robust evidence regarding differences in sleep pro-
files across mental states or BD subtypes in clini-
cally representative populations. Furthermore,
many studies have inadequate statistical power to
explore how sleep profiles differ across mood
states; BD subtypes; and/or lack the capacity to
examine confounding factors or colinearity
between putative discriminating variables.
Aims of the study
This study uses data from a sample of >500
patients with bipolar disorder (BD) recruited from
general psychiatry services across Norway and
explores three unresolved questions:
i) How common are Insomnia and Hypersomnia
in BD?
ii) Are symptoms of Insomnia or Hypersomnia
associated with different subtypes of BD, cur-
rent mental states or treatments, illness history
or other factors (e.g. age and BMI)?
iii) What combinations of variables best differenti-
ate individuals with Insomnia or Hypersomnia
from those with No Sleep Problems?
Material and methods
Sample
The BD cases were recruited via two established
Norwegian research networks exploring the clini-
cal course and outcome of severe mental disorders,
namely the TOP programme (Thematically Orga-
nized Psychosis) and BRAIN (Bipolar Research
and Innovation Network). Whilst ‘BRAIN’ pri-
marily includes patients who have been admitted
or recently discharged from inpatient units
throughout Norway, the ‘TOP’ programme pri-
marily includes patients from outpatient clinics,
most of whom were recruited from services in the
largest city, namely Oslo (17–20). The planned
overlaps in protocols and procedures have allowed
cases from both cohorts to be included in a range
of previously published studies, for example
Schoeyen et al. (21). The research programmes are
approved by ‘The Regional Committee for
Research Ethics’ and ‘The Norwegian Data
Inspectorate’, and all the patients included in the
current project gave written informed consent for
participation.
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The main inclusion criteria for the study were
age ≥18 years and a diagnosis of bipolar disorder
type I or II (BD I; BD II) which was confirmed via
the Structural Clinical Interview for the DSM-IV
(SCID) (22). The exclusion criteria were as follows:
evidence of a primary alcohol or substance abuse
problem and/or a medical disorder that may
account for a sleep disturbance, clinical evidence
of cognitive impairments incompatible with
informed consent for participation and/or absence
of key data regarding BD subtype, mental state or
sleep profile (see below).
Assessments
The BRAIN and TOP programmes record the
same demographic and illness characteristics. Clin-
icians trained in the use of the study assessment
protocol collect information from participants,
which can be supplemented by the patients’ fami-
lies and from clinical records as appropriate. For
this study, information on demographics, BD his-
tory and current treatment were selected from the
database, and current mental state and sleep pro-
file were determined using the symptom ratings
recorded on established, reliable and valid obser-
ver-rated scales:
1. Baseline Characteristics:
a) Demographics: current age, gender, years of
education and body mass index (BMI).
b) History of BD: as in previous TOP-BRAIN
studies, age of BD onset is defined as the age at
which the first mood episode occurred, and ill-
ness duration is defined as the difference between
current age and age of onset (21). In addition,
we report the total number of BD episodes, the
total number of episodes by polarity (depression,
hypomania or mania) and the number of epi-
sodes per annum (calculated from total number
of episodes divided by illness duration in years).
c) Prescribed medications: the total number of
psychotropic medications currently prescribed
to the individual and the classes of those medi-
cations were recorded. The latter were catego-
rized as follows: lithium or anti-epileptics (i.e.
traditional mood stabilizers), antipsychotics,
antidepressants, benzodiazepines and/or
hypnotics.
2. Current Mental State & Sleep Profile:
The clinician version of the Inventory of Depres-
sive Symptomatology (IDS-C) and Young Mania
Rating Scale (YMRS) are interview-based assess-
ments that can be used to record the frequency and
severity of depressive and manic symptoms,
respectively (23, 24). As both questionnaires assess
all the criterion symptom domains designated to
diagnose major mood episodes in DSM-IV and
five, they are frequently used to classify cases as
euthymic, depressed, (hypo)manic or mixed e.g.
Gopal et al., Sussman et al. (25, 26). Furthermore,
several key studies of sleep patterns in mood disor-
ders use the relevant items of the IDS-C or other
symptom rating scales to identify different diag-
nostic subtypes of sleep problems [e.g. Gruber
et al. (14), Kaplan et al. (27), Sylvia et al. (28) and
Soehner et al. (16)]. We used these approaches to
define current mental state and sleep profiles:
a) Current Mental State:
The cut-off scores used to operationalize current
mental states and the rationale for their selection
were based on those employed in a clinical inter-
vention trial for sleep problems in BD (12). To
briefly summarize, the goal was to maximize the
specificity of episode identification (i.e. categoriza-
tion of cases as depressed, hypomanic/manic or
mixed) and minimize misclassifications that may
arise because of conflation of rating scale scores in
those with co-occurring sleep difficulties (due to
the number of sleep items that might be endorsed
in those who were ‘euthymic’ but, e.g., also had
insomnia). The cut-offs selected for hypomania on
the YMRS and depression on the IDS-C are there-
fore at the higher end of those quoted in the litera-
ture, to take into account the number and
potential range of scores on the sleep-related items.
Thus, whilst a standard cut-off on the Hamilton
Rating Scale for Depression (HRSD) for mild
depression is a score of about eight, we selected the
slightly higher level of 11 (which is equivalent to
about 18–19 on the IDS-C; http:\\ www.ids-qid-
s.org). On the YMRS, we used a cut-off of seven as
used in recent sleep studies in BD (29, 30). Thus,
current mental state categories are as follows:
Euthymia/Not in Major Episode = IDS-C <18
and YMRS <7; Depression = IDS-C ≥18 and
YMRS <7; (Hypo)Mania = YMRS ≥8 and IDS-
C <18; Mixed State = YMRS ≥8 and IDS-C ≥18.
b) Sleep Profile:
Whilst the symptom rating scales are not specifi-
cally designed to identify sleep disorders, individ-
ual items are considered to be reliable and valid
‘proxy’ measures of insomnia or hypersomnia
meeting recognized diagnostic criteria as described
in the International Classification of Sleep Disor-
ders and in DSM 5 (28, 31, 32). Also, the sleep
items in the IDS have been validated as measures
of insomnia symptom severity and hypersomnia
severity and shown agreement with multimethod
assessments such as weekly sleep diary recordings,
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clinical interviews (16, 32, 33) and objective mea-
sures such as actigraphy (34).
In this study, sleep profiles (Insomnia, Hyper-
somnia and No Sleep Problems) were operational-
ized from the four sleep items in IDS-C (14, 16, 28,
32, 35): difficulty falling asleep (item 1), difficulty
maintaining sleep (item 2), early morning awaken-
ing (item 3) and hypersomnia (item 4). The follow-
ing definitions were used:
i) Insomnia was regarded as present if the individual
demonstrated one or more of the following
scores: Sleep Onset Insomnia ≥2 (takes at least
30 min to fall asleep, more than half the time),
Mid-nocturnal Insomnia = 3 (awakens more
than once a night and stays awake for 20 min or
more, more than half the time) or Early Morning
Insomnia ≥1 (more than half the time, awakens
more than 30 min before need be) and they
scored zero on the Hypersomnia item (0 = sleeps
no longer than 7–8 h a night, without naps).
ii) Hypersomnia was regarded as present if the
individual had a score ≥1 on the Hypersomnia
item.
iii) An individual was classified with ‘No Sleep
Problems’ if they showed the following scoring
pattern: Sleep Onset Insomnia <2, Mid-noc-
turnal Insomnia <3, Early Morning Insomnia
<2 and Hypersomnia = 0.
Statistical analyses
All analyses were undertaken using SPSS version 21,
(IBM Corp., Armonk, NY, USA) and a signifi-
cance level of P < 0.05 (two-tailed tests) was
employed unless otherwise stated.
Means (and standard deviations; SD) and/or
medians are reported for continuous variables as
appropriate, and numbers and percentages are
reported for categorical variables. Differences
between subgroups were examined using ANOVA for
normally distributed continuous variables,
Kruskal–Wallis tests for non-normal distributions
(statistics reported as X2) and X2 tests for differ-
ences between groups for categorical variables.
Multinomial logistic regression (MNLR) was
used to examine the best combination of variables
that correctly classified cases into three groups
defined by sleep profile (No Sleep Problems,
Insomnia and Hypersomnia). The group without
any sleep problems was selected as the reference
category and the forward (likelihood ratio) proce-
dure was used for the regression. Variables entered
into the model were selected a priori if (a) they
have been reported to be associated with sleep
problems in BD in prior publications (e.g. BD sub-
type, gender, current mental state, BMI and medi-
cation regime) and/or (b) if they had a significance
level <0.05 in the univariate analyses. To avoid
confounding, the YMRS and IDS-C scores were
excluded (as these scales were used to operational-
ize current mental state and sleep categories). The
factors and variables in the MLRN analysis were
as follows: current age, gender, BD subtype, age at
onset of BD, illness duration, number of BD epi-
sodes per annum, current mental state, BMI, and
number and classes of medications prescribed. The
variables included in the final classification model
are reported using odds ratios (OR) with 95% con-
fidence intervals (CI).
Results
Demographics and illness characteristics
As shown in Table 1, the sample comprised of 563
individuals (TOP = 309; BRAIN = 254), of whom
66% met diagnostic criteria for BD I (n = 373).
The mean age at interview was 38 years and the
majority of the sample was female (59%). The
mean body mass index (BMI) was about 26 (SD
4.4). The mean duration of illness was nearly
17 years, with a median of nine BD episodes in
Table 1. Demographics and illness characteristics
Demographics and clinical history n (%)
Total sample 563
Bipolar I: bipolar II 373 (66.3%): 190 (33.7%)
Female: Male 333 (59.1%): 230(40.9%)
Mean (SD)
Age at interview 38.0 (13.4)
Education in years 14.1 (3.0)
Body mass index 25.7 (4.4)
Age at onset of bipolar disorder 21.2 (10.7)
Illness duration in years 16.7 (13.3)
Number of episodes Median (IQR)
Bipolar disorder 9 (4–22)
Per annum (episodes/illness duration) 0.9 (0.5–1.8)
Depression 4 (2–10)
Mania 1 (0–2)
Hypomania 2 (0–6)
Current mental state n (%)
Euthymic 226 (40.1%)
Depressed 212 (37.7%)
(Hypo)manic 73 (13.0%)
Mixed state 52 (9.2%)
Median (IQR)
Inventory of depressive symptoms 17 (10–27)
Young mania rating scale 2 (0–6)
Currently prescribed medications n (%)
No medication 44 (7.8%)
1 mood stabilizer* 381 (67.7%)
≥2 mood stabilizers* 158 (28.1%)
Antipsychotics 329 (58.4%)
Antidepressants 190 (33.7%)
Benzodiazepines 150 (26.6%)
Hypnotics 156 (27.7%)
≥3 medications 244 (43.4%)
*Mood stabilizer refers to Lithium or Anti-epileptics (see text for details).
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total, of which about four were depressive episodes
and three were elevated mood episodes (medians:
Mania = 1; Hypomania = 2). At interview, most
cases were categorized as euthymic (40%) or
depressed (38%), with 13% meeting criteria for
hypomania or mania, and nine per cent were in a
mixed state. The median total IDS score was 17
and the median total YMRS score was two. Less
than 10% of cases were reported to be currently
medication-free. The mean number of medications
being prescribed per person was 2.43 (SD 1.42;
range 0–8). The most commonly prescribed medi-
cations were lithium or an antiepileptic mood sta-
bilizer (68%), followed by antipsychotics (58%);
just over a third of the sample was prescribed
antidepressants and just under a third benzodi-
azepines or hypnotics.
Current sleep profiles
Just less than one-third of the sample had No Sleep
Problems (28%), whilst a similar proportion met
criteria for Hypersomnia (29%). Overall, 43% of
BD cases met criteria for Insomnia, with 29%
meeting criteria for at least two Insomnia subtypes.
As shown in Table 2, the most common Insomnia
symptoms recorded were sleep onset difficulty
(early insomnia = 36%), or waking up too early
(late insomnia = 35%).
Sleep profiles, bipolar subtypes and current mental state
(a) Sleep profiles of bipolar subtypes
As shown in Fig. 1, within the BD I group
(n = 373), 30% cases (n = 113) reported No Sleep
Problems, 38% met criteria for Insomnia
(n = 141), whilst 32% reported Hypersomnia
(n = 119). In BD II (n = 190), the proportions
were as follows: 24% No Sleep Problems (n = 46),
52% Insomnia (n = 99) and 26% Hypersomnia
(n = 45). The prevalence of the three sleep profiles
differs significantly between BD I and BD II (X2
10.61; df 2; P = 0.005)
(b) Current mental state and bipolar subtypes in
groups defined by sleep profile
Within the No Sleep Problem group, there were
no statistically significant differences in the propor-
tion of BD I or II cases who were euthymic,
depressed, (hypo) manic or in a mixed state, about
two-thirds of BD I and II cases were euthymic (see
Table 3). There was a non-significant trend for
more BD I cases to be categorized as (hypo) manic
(26%) and BD II cases as depressed (22%), but
mixed states were rare in both BD I and BD II
cases.
Table 2. Prevalence of different sleep profiles (no sleep problems, insomnia or
hypersomnia)
Sleep profile (n = 563) n (%)
No sleep problems 159 (28.2%)
Hypersomnia 164 (29.1%)
Insomnia 240 (42.6%)
Early (sleep onset) 205 (36.4%)
Middle (mid-nocturnal) 104 (18.5%)
Late (early awakening) 197 (35.0%)
≥2 Insomnias 161 (28.6%)
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Fig. 1. Sleep profile according to mental state in cases with BD I and BD II. As noted in the text and also in Table 3, the prevalence
rates for each sleep profile sub-group differs significantly according to BD subtype (Insomnia vs. Hypersomnia vs. No Sleep Prob-
lems: X2 10.61; df 2; P 0.005).
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Within the Insomnia group, depression was
twice as common in the BD II as compared to the
BD I cases (70% v 34%), whilst (hypo) manic (BD
I = 21%, BD II = 2%) and mixed states (BD
I = 20%; BD II = 9%) were both significantly
more prevalent in BD I cases with Insomnia (X2
36.05; df 3; P = 0.001).
As shown in Table 3, within the Hypersomnia
group, the proportion of BD I and BD II cases
with euthymia (BD I = 50%, BD II = 24%) or
depression (BD I = 38%, BD II = 67%)
accounted for the significant differences that were
observed (X2 11.48; df 3; P 0.009).
Other key characteristics of groups defined by sleep profile
As shown in Table 4, we found no significant dif-
ferences in gender distribution, mean BMI or epi-
sodes per annum between the three sleep
subgroups. Age at interview was significantly lower
in the Hypersomnia group (35.1 years) compared
with the other two subgroups (F 5.67; df 2,560;
P = 0.004), whilst age of onset was significantly
lower in the Insomnia group (19.7 years) compared
with the other groups (F 4.21; df 2,560; P = 0.02).
The Hypersomnia group had the shortest illness
duration compared with the Insomnia group (13
vs. 19 years; F 10.54; df 2,560; P = 0.001).
The proportion of cases who were medication-
free, and the mean number of medications per
person did not differ between groups. Likewise,
rates of prescription of lithium and anti-epileptic
mood stabilizers and of antipsychotics were not
significantly different in the three groups.
Although the proportion of individuals in the
Hypersomnia group who were currently
depressed did not differ significantly from the
other subgroups, more Hypersomnia cases were
being prescribed antidepressants than individuals
in the other groups (Hypersomnia = 42%;
Insomnia = 35%; No Sleep Problems = 23%; X2
13.05, P = 0.01). In contrast, benzodiazepines
and hypnotics were prescribed significantly more
for the Insomnia group (benzodiazepines = 34%;
hypnotics = 35%) than the groups with Hyper-
somnia (benzodiazepines = 17%; hypnotics =
22%) or No Sleep Problems (benzodiazepines
= 26%; hypnotics = 24%).
Multinominal logistic regression (MNLR) model
AMNLR analysis was used to explore which com-
bination of variables best differentiated the Insom-
nia and Hypersomnia groups from the reference
group (No Sleep Problems). Age, gender, BD sub-
Table 3. Comparison of sleep profile and mental state between BD I and BD II
Sleep profile
Current
mental
state
Bipolar I
(n = 373)
Bipolar II
(n = 190) Chi-square P value
No sleep
problems
n = 113 n = 46 6.71 ns
Euthymic 72 (63.7%) 29 (63.0%)
Depressed 10 (8.8%) 10 (21.7%)
(Hypo) manic 29 (25.7%) 6 (13.0%)
Mixed 2 (1.8%) 1 (2.2%)
Insomnia n = 141 n = 99 36.05 0.001
Euthymic 36 (25.5%) 19 (19.2%)
Depressed 48 (34.0%) 69 (69.7%)
(Hypo) manic 29 (20.6%) 2 (2.0%)
Mixed 28 (19.9%) 9 (9.1%)
Hypersomnia n = 119 n = 45 11.48 0.009
Euthymic 59 (49.6%) 11 (24.4%)
Depressed 45 (37.8%) 30 (66.7%)
(Hypo) manic 5 (4.2%) 2 (4.4%)
Mixed 10 (8.4%) 2 (4.4%)
The italic values refer to the total n in the cell.
Table 4. Comparison of characteristics and prescribed medications between sleep profile groups
No sleep problems (n = 159) Insomnia (n = 240) Hypersomnia (n = 164) Statistic* P value
Mean age at interview 38.7 (13.0) 39.5 (13.6) 35.1 (13.2) 5.67 0.004
Females 89 (56%) 138 (57.5%) 106 (64.6%) 2.97 ns
Mean body mass index 25.9 (4.9) 25.4 (4.0) 25.9 (4.5) 0.77 ns
Mean age at onset 22.7 (12.1) 19.7 (10.2) 21.8 (9.7) 4.21 0.02
Mean illness duration 16.0 (12.7) 19.4 (14.0) 13.4 (12.3) 10.54 0.001
Episodes per annum: Mean (SD)/Median 1.5 (2.1)/0.9 1.7 (2.6)/1.0 1.4 (2.2)/1.0 1.36 ns
Medications
None 16 (10.0%) 17 (7.1%) 12 (7.1%) 0.73 ns
1 mood stabilizer† 106 (66.7%) 165 (68.8%) 110 (67.1%) 0.22 ns
≥2 mood stabilizers† 42 (26.4%) 71 (29.5%) 46 (28%) 0.89 ns
Antipsychotics 95 (59.7%) 119 (53.8%) 105 (64.0%) 4.39 ns
Antidepressants 37 (23.3%) 84 (35.0%) 69 (42.1%) 13.05 0.001
Benzodiazepines 41 (25.8%) 81 (33.8%) 28 (17.1%) 13.94 0.001
Hypnotics 37 (23.3%) 83 (34.6%) 36 (22.0%) 9.94 0.007
Mean number of medications 2.26 (1.47) 2.57 (1.50) 2.38 (1.24) 1.61 ns
*ANOVA, chi-square or Kruskal–Wallis test.
†Mood stabilizer refers to lithium or anti-epileptics (see text for details).
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type and current mental state were entered into the
model, followed by age of onset of BD, number of
episodes per year of illness, BMI and number and
classes of psychotropics prescribed. As shown in
Table 5, only two variables significantly differenti-
ated cases with Insomnia from those with No Sleep
Problems: the Insomnia group were significantly
more likely to be depressed (OR 9.46; 95% CI
5.13–17.47; P = 0.001) or in a mixed state (OR
21.38; 95% CI 6.15–74.36; P = 0.001) than the No
Sleep Problems group. Compared to the group
with No Sleep Problems, the Hypersomnia group
was also much more likely to be in a depressed
(OR 6.26; 95% CI 3.29–11.90; P = 0.001) or mixed
state (OR 7.21; 95% CI 1.89–27.49; P = 0.004),
but they showed several additional differences. The
Hypersomnia group was significantly younger (OR
0.97; 95% CI 0.95–0.99; P = 0.011), was more
than twice as likely to meet criteria for BD I (OR
2.12; 95% CI 1.15–3.93; P = 0.016) and to be pre-
scribed antidepressants (OR 2.66; 95% CI 1.23–
5.77; P = 0.013) than the group with No Sleep
Problems. The Hypersomnia group was signifi-
cantly less likely to be in a hypomanic/manic epi-
sode (OR 0.31; 95% CI 0.12–0.77; P = 0.012).
Discussion
This study used definitions of sleep profiles
employed in previous research and applied these to
a large, clinically representative sample of BD
cases recruited from general adult psychiatry ser-
vices. We ascertained that 43% of this sample met
published criteria for Insomnia and 29% for
Hypersomnia, and these sleep profiles differed sig-
nificantly, not only across phases of illness (euthy-
mia, depression, mania or mixed states), but also
by BD subtype (I or II). Previous clinical studies of
sleep problems (vaguely defined) in euthymic BD
reported rates of sleep problems that ranged from
15% (24) to 83% (32); whilst other research has
reported that sleep problems are associated with
BD depression (31, 32), anxiety symptoms (1), BD
subtype (11, 12) and with mental state (11).
None of the available studies have reported the
link between different sleep profiles, BD subtypes
and mental states, and so our study offers addi-
tional important insights. For example, BD I cases
in our study reported high rates of Hypersomnia in
depression and/or euthymia than BD II cases.
Whilst not answering the question of whether sleep
profile is a state or trait marker of BD spectrum or
of BD I (1), these pattern variations highlight two
important aspects of this study. First, sleep prob-
lems in BD may be better understood if the analy-
ses explore associations across combinations of
factors (such as subtypes and mood state), rather
than employing item by item analyses, and second,
that the use of three distinct sleep categories may
explain some of the previous differences in preva-
lence estimates and some apparently contradictory
findings. With the exception of Soehner et al. (13)
(who studied unipolar and BD depressions), previ-
ous clinical studies of sleep patterns in BD have
usually employed only two categories, namely no
sleep problems vs. either (non-specific) sleep prob-
lems or insomnia.
Previous publications rarely controlled for
potential confounders that might explain some of
the apparent associations between sleep patterns
and clinical or individual characteristics (1, 14–16,
28, 35, 36). When group comparisons and/or logis-
tic regression analyses take account of other vari-
ables (such as age, gender, BMI, medications, and
clinical and illness characteristics), the only fea-
tures that differentiated Insomnia from the No
Sleep Problems group were being depressed (OR
>9) or being in a mixed state (OR >20). Also, the
95% confidence intervals for these odds ratios were
wide, suggesting some caution is needed in inter-
preting these findings. Some support for these find-
ings comes from Gruber et al. (14), who defined
cases according to sleep duration and found that
short sleepers had higher levels of mood elevation
and of depressive symptoms, whilst long sleepers
were characterized by more depressive symptoms.
The Hypersomnia group compared with the
Insomnia group was younger, had a shorter mean
illness duration and was less likely to be prescribed
hypnotics and benzodiazepines. In contrast, the
Insomnia group had a younger age of onset than
the Hypersomnia group. However, it should be
noted that whilst the definitions employed in this
Table 5. Multinominal logistic regression model of the best combination of vari-
ables that differentiate Insomnia and Hypersomnia groups from the ‘No Sleep Prob-
lems’ group
Insomnia Hypersomnia
Age at Interview OR 0.97 (95% CI 0.95–0.99)
Diagnosis of
bipolar I disorder
OR 2.12 (95% CI 1.15–3.93)
Prescribed
antidepressants
OR 2.66 (95% CI 1.23–5.77)
Depressive episode OR 9.46 (95% CI 5.13–17.47) OR 6.26 (95% CI 3.29–11.90)
Mixed state OR 21.38 (95% CI 6.15–74.36) OR 7.21 (95% CI 1.89–27.49)
Hypomanic/Manic
episode
OR 0.31 (95% CI 0.12–0.77)
OR, odds ratio; 95% CI, 95% confidence intervals.
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study preclude the possibility that individuals meet-
ing the criteria for Insomnia would simultaneously
have Hypersomnia, it is potentially feasible for a
subpopulation of the Hypersomnia group to have
some symptoms of Insomnia. Whilst we have no
evidence that this attenuated any differences
between the groups with sleep problems, the poten-
tial Insomnia–Hypersomnia constellation warrants
further examination. Cases with Hypersomnia
were also significantly more likely to be in a
depressed or a mixed state compared to the No
Sleep Problems group, but Hypersomnia was not
associated with pure (hypo) mania. In this study, it
appears that Hypersomnia can be associated with
any mental state that includes a significant depres-
sive component (both depression and mixed
states). Interestingly, the Hypersomnia group was
significantly younger and was twice as likely to
have BD I compared with the No Sleep Problems
group. There are few clinical studies of sleep pro-
files in BD that have examined Hypersomnia; but
in a mixed unipolar and BD sample, Soehner et al.
(16) also reported that hypersomnia was associated
with younger age. The final factor that character-
ized the Hypersomnia group was that the cases
were more likely to be prescribed antidepressants
compared with the No Sleep Problems group and
antidepressants are associated with both increased
somnolence and insomnia. The only previous
study that examined prescribing in individuals with
BD and sleep problems did not find any differences
in medication class or load between individuals
with or without hypersomnia (32). It is unclear
why the Hypersomnia cases in our study were
more often prescribed antidepressants, especially
as the overall rate of depression did not appear to
differ significantly from the other groups. One pos-
sible, but speculative, explanation is that the
Hypersomnia cases may have had more persistent
and severe depressive symptoms than other cases
(and were therefore prescribed more medication),
whilst another possibility is that some antidepres-
sants may actually contribute to the excessive
sleepiness (37). Whilst this cannot be proven on
the basis of our data, it is noteworthy that Gruber
et al. reported that long sleepers showed signifi-
cantly higher levels of disability, than other BD
cases (14).
Although this study tried to learn methodologi-
cal lessons from earlier clinical studies of sleep pro-
files in BD; several limitations should be
acknowledged. First, the cross-sectional design
means we can only examine statistical associations,
not predictors of sleep profile or the downstream
consequences of these different patterns. Second,
although we could identify cases with symptom
levels indicative of euthymia, we could not deter-
mine how long they had been euthymic. Third, we
relied on definitions of sleep profiles that have been
employed in previous studies, which categorize the
problems according to item ratings on established
symptom scales, rather than using formal diagnos-
tic criteria (16, 28). As an example, our definition
of Hypersomnia did not include an assessment of
daytime sleepiness. As such, our groups are more
accurately regarded as signifying sleep profiles, or
symptoms of sleep problems, not diagnostic cate-
gories or full syndromes. Having said that,
research comparing the reliability and validity of
these ratings to objective measures or other assess-
ments of sleep patterns demonstrates that these
profiles offer acceptable representations of the
underlying diagnostic categories (16, 38). This
could be further improved by supplementing the
ratings derived from the mood symptom scales
with specific sleep questionnaires (e.g. PSQI) (39).
In addition, we did not know the percentage of
patients with obstructive sleep apnoea which is fre-
quent in patients with BD and can potentially
explain parts of the rates of sleep problems (40).
Lastly, we did not include any objective sleep mea-
surements. However, our rationale was that tech-
niques such as actigraphy and polysomnography
are more costly and resource intensive, and our
primary goal was to reflect the measures used to
evaluate sleep profiles in BD from the perspective
of day to day clinical practice.
As noted, strengths of this study include the use
of a large sample recruited from routine clinical set-
tings and that data collection was undertaken by
independent trained interviewers who were blind to
the hypotheses being tested. Also, we examined
combinations of variables that best classified cases
into groups according to their sleep profile and
took into account potential confounders that have
not been routinely examined in other studies. How-
ever, we are aware that additional characteristics
will need to be considered in future research, such
as seasonality, obstructive sleep apnoea, physical
illnesses and their treatments.
Sleep problems may be a cause of BD episodes
or a core symptom of an episode (1). Studies of
psychopathology also highlight that sleep profiles,
such as hypersomnia in ‘atypical’ depression, or
insomnia as a (transdiagnostic) marker of sympa-
thetic arousal, may be important indicators of a
bipolar or unipolar course of illness and/or pre-
dict response to treatment in BD cases (10, 11).
Such findings highlight the importance of under-
taking regular, detailed assessments of sleep pro-
files in individuals with mood disorders and
giving due consideration to how the treatment of
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BD may impact (positively or negatively) on sleep
patterns. However, further impetus is given to this
issue because DSM 5 has now recommended that
sleep disorders are no longer classified as primary
or secondary. The likely implication is that sleep
problems in individuals with BD are more likely
to receive specific clinical attention and that treat-
ments directly targeting a particular sleep profile
will be introduced (rather than relying on indirect
effects on sleep of generic BD treatments). To tar-
get interventions effectively, we will need to build
on this and other clinical research studies to
develop a more detailed understanding of the
range and nature of sleep problems that occur
within and across BD subtypes and mental states.
Only then will it be possible to ensure that more
sophisticated, evidence-based treatments are insti-
gated.
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